Predictive Oncology Inc. (POAI) SEC Filing 8-K Material Event for the period ending Friday, September 27, 2019

Predictive Oncology Inc.

CIK: 1446159 Ticker: POAI

View differences made from one to another to evaluate Predictive Oncology Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Predictive Oncology Inc..


Assess how Predictive Oncology Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Predictive Oncology Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: POAI
CIK: 1446159
Form Type: 8-K Corporate News
Accession Number: 0001171843-19-006203
Submitted to the SEC: Mon Sep 30 2019 1:00:17 PM EST
Accepted by the SEC: Mon Sep 30 2019
Period: Friday, September 27, 2019
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies
  1. Financial Exhibit
  2. New Agreement
  3. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: